GGrantIndex
← Leaderboards

Sunil Sudarshan

University Of Texas Hlth Science Center

$4,229,836
Attributed
$4,229,836
Total exposure
5
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $423.3K · FY200925
$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,229,836 · 4
VA$0 · 1

By mechanism

R01$3,209,624 · 1
K08$864,000 · 1
P30$156,212 · 2
I01$0 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Texas Hlth Science Center

Same institution · by research overlap

Others in their field

Top investigators on “Tumor

Research focus

TumorPhenotypeRenal Cell CarcinomaMetabolismRenal CarcinomaMalignant NeoplasmsKidneyMolecularWomanIn VivoLinkMediatingPathway InteractionsMetabolicCancer CellNovel TherapeuticsInnovationNovel Therapeutic InterventionMetabolic PathwayNeoplasm MetastasisGene ExpressionGenesMitochondriaNovel Strategies

Grant awards (28)

Interaction between the Epitranscriptome and Metabolism in L-2HG Driven Kidney Cancer$371,250
R01 · FY2025 · CA · contact PI
HDAC7-driven metabolic remodeling in renal tumor progression$0
I01 · FY2025 · VA · contact PI
Interaction between the Epitranscriptome and Metabolism in L-2HG Driven Kidney Cancer$352,687
R01 · FY2024 · CA · contact PI
01 - Cancer Biology & Immunology$52,072
P30 · FY2024 · CA · contact PI
HDAC7-driven metabolic remodeling in renal tumor progression$0
I01 · FY2024 · VA · contact PI
Interaction between the Epitranscriptome and Metabolism in L-2HG Driven Kidney Cancer$363,825
R01 · FY2023 · CA · contact PI
01 - Cancer Biology & Immunology$52,070
P30 · FY2023 · CA · contact PI
HDAC7-driven metabolic remodeling in renal tumor progression$0
I01 · FY2023 · VA · contact PI
Interaction between the Epitranscriptome and Metabolism in L-2HG Driven Kidney Cancer$371,250
R01 · FY2022 · CA · contact PI
01 - Cancer Biology & Immunology$52,070
P30 · FY2022 · CA · contact PI
Renal Cancer Metastasis: Molecular Mechanisms to Therapy$0
I01 · FY2022 · VA · contact PI
Renal Cancer Metastasis: Molecular Mechanisms to Therapy$0
I01 · FY2021 · VA · contact PI
Regulation of the Kidney Cancer Epigenome by Oncometabolite L-2-Hydroxyglutarate$338,596
R01 · FY2020 · CA · contact PI
Renal Cancer Metastasis: Molecular Mechanisms to Therapy$0
I01 · FY2020 · VA · contact PI
Regulation of the Kidney Cancer Epigenome by Oncometabolite L-2-Hydroxyglutarate$328,423
R01 · FY2019 · CA · contact PI
Renal Cancer Metastasis: Molecular Mechanisms to Therapy$0
I01 · FY2019 · VA · contact PI
Regulation of the Kidney Cancer Epigenome by Oncometabolite L-2-Hydroxyglutarate$350,821
R01 · FY2018 · CA · contact PI
Reprogramming of Mitochondrial Metabolism in Renal Cancer$0
I01 · FY2018 · VA · contact PI
Regulation of the Kidney Cancer Epigenome by Oncometabolite L-2-Hydroxyglutarate$360,662
R01 · FY2017 · CA · contact PI
Reprogramming of Mitochondrial Metabolism in Renal Cancer$0
I01 · FY2017 · VA · contact PI
Regulation of the Kidney Cancer Epigenome by Oncometabolite L-2-Hydroxyglutarate$372,110
R01 · FY2016 · CA · contact PI
Reprogramming of Mitochondrial Metabolism in Renal Cancer$0
I01 · FY2016 · VA · contact PI
Reprogramming of Mitochondrial Metabolism in Renal Cancer$0
I01 · FY2015 · VA · contact PI
Role of fumarate hydratase in renal hypoxia and tumorigenesis$172,800
K08 · FY2013 · CA · contact PI
Role of fumarate hydratase in renal hypoxia and tumorigenesis$172,800
K08 · FY2012 · CA · contact PI
Role of fumarate hydratase in renal hypoxia and tumorigenesis$172,800
K08 · FY2011 · CA · contact PI
Role of fumarate hydratase in renal hypoxia and tumorigenesis$172,800
K08 · FY2010 · CA · contact PI
Role of fumarate hydratase in renal hypoxia and tumorigenesis$172,800
K08 · FY2009 · CA · contact PI